Director/PDMR Shareholding

RNS Number : 4006A

AstraZeneca PLC

28 September 2015

 



Transactions by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 25 September 2015, Dr Sean Bohen, EVP, Global Medicines Development & Chief Medical Officer, a person discharging managerial responsibilities, was granted awards under the terms of the AstraZeneca Performance Share Plan (AZPSP) and the AstraZeneca Restricted Share Plan (AZRSP) over the Company's American Depositary Shares (ADSs). Two ADSs equal one Ordinary Share of US$0.25 each.

Name	ADSs awarded under AZPSP	ADSs awarded under AZRSP	Award price per ADS
Sean Bohen	16,003	51,802	$32.32

The AZPSP award is subject to a combination of performance measures focused on AstraZeneca's scientific, commercial and financial performance assessed over a three-year performance period (1 January 2015 to 31 December 2017). The award will vest on the third anniversary of the date on which it was granted.

The AZRSP award will vest, subject to Dr Bohen's continued employment with the Company, as follows:

25,901 ADSs will vest on 25 September 2016

25,901 ADSs will vest on 25 September 2017

A C N Kemp

Company Secretary

28 September 2015

 

END

 

 

RDSUWOARVOAKUAR